Key result
Extracorporeal membrane oxygenation (ECMO) for ARDS showed weak evidence of efficacy for mortality reduction, failing to exclude a null effect.
Why the study?
The role of ECMO in the treatment of ARDS remains controversial despite recent trial results, with uncertainty about its efficacy and economic outcomes.
Does extracorporeal membrane oxygenation (ECMO) reduce mortality in patients with acute respiratory distress syndrome (ARDS)?
Meta-Analysis
Does extracorporeal membrane oxygenation (ECMO) reduce mortality in patients with acute respiratory distress syndrome (ARDS)?
Answers are grounded in this paper and cite their sources.
A Bayesian meta-analysis of three RCTs shows weak evidence for ECMO efficacy in ARDS, suggesting it should be reserved as rescue therapy pending further trials.
The role of extracorporeal membrane oxygenation (ECMO) in the treatment of the acute respiratory distress syndrome (ARDS) is controversial, notwithstanding the recent publication of the results of the CESAR (Conventional Ventilation or ECMO for Severe Adult Respiratory Failure) trial. Using Bayesian meta-analytic methods from three randomised controlled trials (RCTs) of ECMO in ARDS, we estimate the mortality odds ratio to be 0.78 (95% credible interval, 0.25-3.04), P (OR > 1) = 30%. Thus, a null effect of ECMO is not excluded and there appears only weak evidence of efficacy. We survey particular problems associated with the conduct of the "pragmatic" CESAR trial: composite endpoints, sample size estimation under uncertainty of baseline mortality rates, the generation of unbiased treatment comparisons, the impact of treatment non-compliance, and the uncertainty associated with cost-effectiveness and cost-utility analysis. We conclude that the CESAR trial is problematic in terms of both the clinical and economic outcomes, although observational series suggest plausible efficacy. We suggest that ECMO finds rationale as rescue therapy and that the current uncertainty of its role mandates a further RCT.
No takes yet. Share an insight, caveat, or question.
Moran et al. (2010) conducted a meta-analysis in Acute respiratory distress syndrome (ARDS). Extracorporeal membrane oxygenation (ECMO) vs. Conventional ventilation was evaluated on Mortality (OR 0.78, 95% CI 0.25-3.04, p=P (OR > 1) = 30%). Extracorporeal membrane oxygenation (ECMO) for ARDS showed weak evidence of efficacy for mortality reduction, failing to exclude a null effect.
Synapse has enriched 10 related papers. Consider them for comparative context: